News

AvePoint, Inc. (AVPT) Q3 2023 Earnings Call Transcript

22 Mins read

AvePoint, Inc. (NASDAQ:AVPT) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET

Company Participants

James Arestia – VP, IR

Tianyi Jiang – Co-Founder and CEO

James Caci – CFO

Conference Call Participants

Fatima Boolani – Citi

Chirag Ved – Evercore ISI

Nehal Chokshi – Northland Capital Markets

Derrick Wood – TD Cowen

Jason Ader – William Blair

Operator

Good day and welcome to the AvePoint Inc. Q3 2023 Earnings Call. Today, all participants will be in a listen-only mode. [Operator Instructions] After today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note that today’s event is being recorded.

I would now like to turn the conference over to Jamie Arestia, Vice President, Investor Relations. Please go ahead, sir.

James Arestia

Thank you, operator. Good afternoon and welcome to AvePoint’s third quarter 2023 earnings call. With me on the call this afternoon is Dr. TJ Jiang, Chief Executive Officer; and Jim Caci, Chief Financial Officer. After preliminary remarks, we will open the call for a question-and-answer session.

Please note that this call will include forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from management’s current expectations. We encourage you to review the Safe Harbor statements contained in our press release for a more complete description. All material in the webcast is the sole property and copyright of AvePoint with all rights reserved.

Please note this presentation describes certain non-GAAP measures, including non-GAAP operating income and non-GAAP operating margin, which are not measures presented in accordance with U.S. GAAP. The non-GAAP measures are presented in this presentation as we believe they provide investors with the means of evaluating and understanding how management evaluates the company’s operating performance. These non-GAAP measures should not be considered in isolation from, a substitute for, or superior to financial measures prepared

Read the full article here

Related posts
News

CI&T Inc. 2025 Q1 - Results - Earnings Call Presentation (NYSE:CINT)

1 Mins read
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We…
News

November Winners | Seeking Alpha

1 Mins read
The average stock in the large-cap Russell 1000 rose 9.77% in November, and 38 stocks gained more than 30%, 14 rallied more…
News

Following Up On Fulgent Genetics (NASDAQ:FLGT)

3 Mins read
Try not to become a man of success. Rather become a man of value.”― Albert Einstein. Today, we put Fulgent Genetics, Inc….
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *